A placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee.
J van Rooij , G H van der Stegen , R C Schoemaker , C Kroon
The American Journal of Clinical Nutrition 61 ( 6) 1277 -1283
39
1995
Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant.
P Hoever , S de Haas , J Winkler , R C Schoemaker
Clinical Pharmacology & Therapeutics 87 ( 5) 593 -600
89
2010
Effects of temazepam on saccadic eye movements: Concentration-effect relationships in individual volunteers
Alfred L van Steveninck , Susanne Verver , Hendrik C Schoemaker , Monique S M Pieters
Clinical Pharmacology and Therapeutics 52 ( 4) 402 -408
31
1992
A comparison of the sensitivities of adaptive tracking, eye movement analysis, and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers
Alfred L van Steveninck , Hendrik C Schoemaker , Monique S M Pieters , Ria Kroon
Clinical Pharmacology & Therapeutics 50 ( 2) 172 -180
94
1991
Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans
Paul A Soons , Birgit A P M Vogels , Margret C M Roosemalen , Hendrik C Schoemaker
Clinical Pharmacology and Therapeutics 50 ( 4) 394 -403
122
1991
Effects of intravenous temazepam. II. A study of the long-term reproducibility of pharmacokinetics, pharmacodynamics, and concentration-effect parameters
Alfred L Van Steveninck , Hendrik C Schoemaker , Jan Den Hartigh , M Pieters
Clinical Pharmacology and Therapeutics 55 ( 5) 546 -555
6
1994
Effects of intravenous temazepam. I. Saccadic eye movements and electroencephalogram after fast and slow infusion to pseudo steady state
Alfred L Van Steveninck , Hendrik C Schoemaker , Jan Den Hartigh , Jolanda Rijnkels
Clinical Pharmacology and Therapeutics 55 ( 5) 535 -545
12
1994
Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy volunteers: an interethnic comparative study between Japanese and European volunteers.
H. Yasuhara , E. Uchida , M. S. M. Pieters , S. J. de Visser
The Journal of Clinical Pharmacology 38 ( 12) 1129 -1136
14
1998
Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin.
W. C. J. Hop , H. J. Neijens , R. De Groot , J. N. Van Den Anker
British Journal of Clinical Pharmacology 40 ( 5) 439 -443
30
1995
Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
F. J. F. Broeyer , S. Osanto , H. J. Ritsema van Eck , A. Q. M. J. van Steijn
Journal of Cancer Research and Clinical Oncology 134 ( 9) 961 -968
35
2008
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants.
M. J. B. Kemme , R. A. Faaij , R. C. Schoemaker , C. Kluft
Blood Coagulation & Fibrinolysis 12 ( 7) 583 -591
17
2001
Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks.
J. J. Huisman-de Boer , J. N. van den Anker , M. Vogel , W. H. Goessens
Antimicrobial Agents and Chemotherapy 39 ( 2) 431 -434
44
1995
Once-daily versus twice-daily administration of ceftazidime in the preterm infant.
J. N. van den Anker , R. C. Schoemaker , B. J. van der Heijden , H. M. Broerse
Antimicrobial Agents and Chemotherapy 39 ( 9) 2048 -2050
16
1995
The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.
M. S. M. Pieters , A. F. van Steveninck , R. C. Schoemaker , J. M. Kroon
Journal of Psychopharmacology 17 ( 3) 269 -272
6
2003
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.
J. P. van der Post , S. J. de Visser , R. C. Schoemaker , A. F. Cohen
Journal of Psychopharmacology 18 ( 2) 221 -227
14
2004
The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation
A. L. van Steveninck , B. N. M. van Berckel , R. C. Schoemaker , D. D. Breimer
Journal of Psychopharmacology 13 ( 1) 10 -17
83
1999
Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects
S. J. De Visser , J. M. A. Van Gerven , R. C. Schoemaker , A. F. Cohen
British Journal of Clinical Pharmacology 51 ( 5) 423 -428
12
2001
Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin.
R. A. Faaij , J. Burggraaf , R. C. Schoemaker , R. G. M. Van Amsterdam
British Journal of Clinical Pharmacology 54 ( 3) 304 -308
14
2002
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
J. M. A. Van Gerven , G. Roncari , R. C. Schoemaker , J. Massarella
British Journal of Clinical Pharmacology 44 ( 5) 487 -493
39
2003
A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas–kidney transplant recipients
S. C. L. M. Cremers , E. M. Scholten , R. C. Schoemaker , E. G. W. M. Lentjes
Nephrology Dialysis Transplantation 18 ( 6) 1201 -1208
51
2003